Related references
Note: Only part of the references are listed.Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling
Marie-Alice Meuwis et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H. Uhlig et al.
IMMUNITY (2006)
Serologic markers in inflammatory bowel disease
X Bossuyt
CLINICAL CHEMISTRY (2006)
A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease
K Mitsuyama et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Emerging roles for ectodomain shedding in the regulation of inflammatory responses
Kyle J. Garton et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Down-regulation of endothelial adhesion molecules and leukocyte adhesion by treatment with superoxide dismutase is beneficial in chronic immune experimental colitis
J Segui et al.
INFLAMMATORY BOWEL DISEASES (2005)
Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice:: correlation between symptoms and inflammation
S Melgar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease
F Magro et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis
MH Myles et al.
INFECTION AND IMMUNITY (2003)
Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease
D Foell et al.
GUT (2003)
Serum YKL-40, a potential new marker of disease activity in patients with inflammatory bowel disease
I Vind et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Serum interleukin-18 concentrations in patients with inflammatory bowel disease
D Furuya et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Share Paper
